PDA

View Full Version : Medical Articles and Abstracts


Pages : 1 [2] 3 4

  1. A prospective study investigating the cost effectiveness of intraoperative blood salv
  2. Cost, quality, and risk: measuring and stopping the hidden costs of coronary artery b
  3. Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia management.
  4. Comparison of lactated Ringer's, gelatine and blood resuscitation on intestinal oxyge
  5. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery
  6. Blood transfusion is associated with infection and increased resource utilization in
  7. Does salvage and tranexamic acid reduce the need for blood transfusion in revision hi
  8. Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasia
  9. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill
  10. Perioperative use of recombinant activated factor VII in a Jehovah's Witness patient
  11. Blood loss after total hip replacement: a prospective randomized study between wound
  12. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a
  13. Perioperative intravenous iron, with or without erythropoietin
  14. Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to
  15. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controll
  16. Blood transfusion is associated with infection and increased resource utilization
  17. The association between duration of storage of transfused red blood cells and morbid
  18. Effects of cell saver autologous blood transfusion on blood loss and homologous blood
  19. New generation cytokines to prevent anemia and febrile neutropenia
  20. Pediatric critical care community survey of knowledge and attitudes toward therapeuti
  21. Therapeutic hypothermia utilization among physicians after resuscitation from cardiac
  22. Absorbable laparoscopic cigarette sponge.
  23. Resolving the paradigm crisis in intravenous iron and erythropoietin management.
  24. Blood management in total joint arthroplasty
  25. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systemati
  26. Developing a blood conservation program in cardiac surgery.
  27. A provincial program of blood conservation: The Ontario Transfusion Coordinators (ONT
  28. The effect of older blood on mortality, need for ICU care, and the length of ICU stay
  29. Massive transfusion as a risk factor for acute lung injury: association or causation?
  30. Are i-STAT results adversely affected by an artificial blood substitute in vivo?
  31. Early administration of a second-generation perfluorochemical decreases ischemic brai
  32. Socioeconomic costs of open surgery and gamma knife radiosurgery for benign cranial b
  33. Brain Surgery Without The Surgery?
  34. Pneumonia as a complication of blood product transfusion
  35. Substitute blood development suffers blow
  36. Special scalpel reduces blood loss, facial nerve trauma in salivary surgery
  37. Older Blood Associated With Worse Outcomes After Repeat Heart Surgery
  38. Minimally Invasive Procedure Restores Blood Flow To Kidneys, Research Suggests
  39. Pancreaticoduodenectomy after neoadjuvant therapy in a Jehovah's witness with locally
  40. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery
  41. Erythropoietin: can we afford to use it? Can we afford not to?
  42. Safety aspects of aprotinin therapy in cardiac surgery patients.
  43. Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Car
  44. TRALI in 2 Cases of Leukemia.
  45. TRALI-Soluble CD40 ligand accumulates in stored blood components, primes neutrophils
  46. Blood management in intensive care medicine: CRIT and ABC – what can we learn?
  47. The effects of colloid solutions on hemostasis
  48. Erythropoietin is an effective clinical modality for reducing RBC transfusion
  49. Transfusion in CABG is associated with reduced long-term survival
  50. Thoracoscopic Spinal Fusion Compared with Posterior Spinal Fusion
  51. Morbidity and mortality risk associated with red blood cell and blood-component trans
  52. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of rand
  53. Perioperative blood transfusions increase infectious complications after ileoanal po
  54. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass gra
  55. Effect of blood transfusion on outcome after major burn injury: A multicenter study
  56. Iron-Clad Solutions to Anemia
  57. Comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery
  58. Effectiveness of Darbepoetin-Alfa in Combination with Intravenous Iron Sucrose
  59. Blood Transfusions Could Transmit Variant Creutzfeldt-Jakob
  60. A prospective randomized trial toward a "blood transfusion"-free hepatectomy.
  61. Blood utilisation in elective surgery cases: requirements, ordering and transfusion
  62. Timing of the administration of tranexamic acid for maximum reduction in blood loss
  63. An audit of blood cross-match ordering practices at the Aga Khan University Hospital
  64. UK - The impact of a 10-year audit cycle on blood usage in district general hospital
  65. Use of red blood cell transfusions in surgery
  66. The quest for quality blood banking program in the new millennium the American way
  67. A questionnaire study about perioperative blood transfusion
  68. New blood transfusion system of the Saku Central Hospital--conditions and problems
  69. [Allogeneic blood transfusion policy in orthopedic surgery]
  70. A study of blood cross-matching requirements for surgery in gynecological oncology: i
  71. Transfusion-free cardiopulmonary bypass in Jehovah's Witness patients weighing <5kg
  72. Blood transfusions linked - increased mortality - patients suffering cardiac episodes
  73. Rethinking blood shield statutes in view of the hepatitis C pandemic
  74. Babesiosis and blood transfusion: flying under the radar
  75. Aprotinin in cardiac surgery
  76. The potential for reintroduction of tumor cells during intraoperative blood salvage:
  77. Recent developments - Blood transfusion medicine
  78. New Research Emerges on Dangers of Blood Loss
  79. Commonly Used Drug in Heart Surgery May Increase Risk of Death
  80. NEJM - The Risk Associated with Aprotinin in Cardiac Surgery
  81. Heart attack patients do better in America's “best” hospitals
  82. Cancer Patients Do Better With Surgeons, Hospitals That Treat Higher Volume
  83. Heart Attack Patients Do Best at Hospitals That Specialize
  84. NovoSeven - Off-Label Use of Hemophilia Drug May Be Risky
  85. Results- Perfusion.com Cardiac Hematocrit Trend Survey:Observations/Recommendations
  86. Immunosuppression, Skin Cancer, and Ultraviolet A Radiation
  87. Cardiac Surg Abstracts
  88. Blood ordering protocol based on proposed surgical implant in fractured neck of femur
  89. Can EPO reduce blood transfusion requirements induction therp high-risk neuroblastoma
  90. Effect of substituting allogenic blood transfusion with autologous blood transfusion
  91. Allogeneic blood transfusion and wound healing disturbance after orthopaedic surgery
  92. The transfusion services committee--responsibilities and response to adverse transfus
  93. Getting the right blood to the right patient
  94. Alternative to platelet transfusion in aplastic anemia
  95. Long-term transfusion of polymerized bovine hemoglobin in a Jehovah's Witness followi
  96. Off-Pump Repair of a Giant Pseudoaneurysm of a Distal Saphenous Vein Bypass Graft
  97. Overview of Clinical Efficacy and Safety of Pharmacologic Strategies for Blood Conser
  98. Blood Conservation Strategy Can Eliminate Phlebotomy Waste
  99. Blood conservation in pediatric anesthesia
  100. Blood conservation in the critically ill patient
  101. Artificial oxygen carriers as an alternative to red blood cell transfusion
  102. Transfusion management
  103. Evaluation and management of bleeding during cardiac surgery
  104. Bloodless surgery of acute type A aortic dissection in a Jehovah's Witness patient
  105. Theme issue on Ontario initiatives in blood conservation and blood management
  106. A provincial program of blood conservation The Ontario Transfusion Coordinators-ONTC
  107. Overview of clinical efficacy and safety of pharmacologic strategies for blood conser
  108. Are we doing everything we can to conserve blood during bypass? A national survey
  109. Hemobag - Article shows Blood Reduction in Cardiac Surgery
  110. .... lifeline for saving the critically injured on the battllefield
  111. Common Anemias
  112. Blood management strategies for critical care patients
  113. A Practical Approach to Achieving Bloodless Surgery.
  114. Clinical results of Perftoran application: present and future
  115. Surgeries on gastrointestinal tract without components of donor's blood
  116. Preoperative embolization of intracranial meningiomas with Embosphere microspheres
  117. Bloodless treatment of infants with haemolytic disease
  118. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy.
  119. Determinants of red blood cell transfusions in a pediatric critical care unit: A pros
  120. Transfusion-transmitted infection in hemophilia in developing countries.
  121. Current trends in blood conservation in total knee arthroplasty
  122. Preoperative iron supp and intraoperative transfusion colorectal cancer surgery
  123. Blood conservation: the CEO perspective
  124. Cardiopulmonary bypass: it's not the size, it's how you use it! Blood Conservation
  125. Transfusion-free pediatric burn surgery: techniques and strategies.
  126. Impact of extracorporeal circuit prime volume reduction on whole blood sequestration
  127. Orthopaedic-induced anemia: the fallacy of autologous donation programs
  128. Intraoperative blood salvage: fluid replacement calculations
  129. Red Cell Transfusion "Trigger": A Review
  130. Indications for Blood Transfusion in Critical Care Patients Reviewed CME
  131. No-Transfusion Liver Graft in Surgical Tour de Force
  132. Cardioprotective effects of acute normovolemic hemodilution in patients undergoing co
  133. Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobi
  134. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injure
  135. Evaluation and management of bleeding during cardiac surgery
  136. Aprotinin decreases postoperative bleeding and number of transfusions in patients on
  137. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery
  138. Preoperative erythropoietin therapy
  139. Know more about Chagas Disease
  140. ESC: Lovenox Reduces Bleeding in Elective Angioplasty
  141. Blood Conservation
  142. Recombinant Human Erythropoietin Use in a Critically Ill Jehovah’s Witness After Card
  143. Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion CABG
  144. Restoring Flow to All Blocked Areas of the Heart Improves 5-Year Survival Rate
  145. Hep C-Related Deaths Expected to Triple over Next 10 Years; New Treatments Years Off
  146. New UK Guidance to be issued on Hepatitis C as 'silent epidemic'
  147. Safety Of Polymerizedbovine Hemoglobin As Compared To Rbc
  148. Heart attack patients who receive blood transfusions have higher death rate
  149. Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors.
  150. Therapeutic approaches in trauma-induced coagulopathy.
  151. Which may be effective to reduce blood loss after cardiac operations in cyanotic chil
  152. Coagulation disorders and blood product use in patients undergoing thoracoabdominal a
  153. Aprotinin inhibits protease-dependent platelet aggregation and thrombosis.
  154. Evidence-based review of the role of aprotinin in blood conservation during orthopaed
  155. A review of aprotinin in orthotopic liver transplantation: can its harmful effects of
  156. Therapeutic approaches in trauma-induced coagulopathy.
  157. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin
  158. Number needed to treat and cost of recombinant human EPO to avoid one transfusion
  159. Cost-effectiveness of recombinant human erythropoietin for reducing RBC Transfusion
  160. Use of acute normovolemic hemodilution in patients undergoing radical prostatectomy
  161. The safety and efficacy of "bloodless" cardiac surgery
  162. To do or not to do living donor hepatectomy in Jehovah's Witnesses
  163. Clinical Outcomes in Cardiac Surgery: Conventional Surgery versus Bloodless Surgery
  164. Study Gives Survival Edge to CABG Over Stenting
  165. Parens Patriae explained - (We need a legal forum!!)
  166. Current Issues in Transfusion Medicine, An Issue of Anesthesiology Clinics
  167. 1976 Article - Old and new dangers of blood transfusion
  168. 1968 Article - Assessment of risk and danger of blood transfusion
  169. 1963 Article - THE INCREASED IMMUNOLOGICAL DANGER OF MULTIPLE TRANSFUSIONS
  170. 1950 Article - Danger of leukemia transmission by blood transfusion
  171. 1951 Article - The extent of danger in intrasternal blood transfusion
  172. 1952 Article - DANGER of blood transfusion
  173. 1953 Article - WORLD Health Organization; danger of spreading jaundice through BT
  174. 1953 Article - Danger of universal donors
  175. 1955 Article - The problem of reducing the danger of serum
  176. 1956 Article - Pyrogenic substances as a source of danger in blood transfusion
  177. 1957 Article - The danger of transmission of Chagas' disease by blood transfusion
  178. 1953 Article - BLOOD transfusion: danger of serum hepatitis
  179. [Radiofrequency ablation of liver tumours]
  180. Usefulness of vacuum-assisted cardiopulmonary bypass circuit for pediatric open-heart
  181. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: l
  182. Randomized trial of normal saline solution injection versus bipolar electrocoagulatio
  183. Partial nephrectomy using a vascular sealing system.
  184. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor
  185. Argon beam coagulation for post-tonsillectomy hemostasis.
  186. Effect of hypoventilation on bleeding during hepatic resection: a randomized controll
  187. Prediction of therapeutic failure after adrenaline injection plus heater probe treatm
  188. The effects of quantum energy surgical device and of bipolar coagulation: a comparati
  189. Minimising intra-operative blood loss.
  190. Minimal blood loss in patients undergoing radical retropubic prostatectomy
  191. Prophylactic positive end-expiratory pressure and reduction of postoperative blood lo
  192. Progress in ascending and aortic arch surgery: minimally invasive surgery, blood cons
  193. The use of tourniquets in the excision of unexsanguinated extremity burn wounds.
  194. Argon beam coagulation during caesarean section.
  195. Reoperation in a Jehovah's Witness 22 years after aortic allograft reconstruction of
  196. How we do a bloodless partial splenectomy
  197. Laparoscopic nephron-sparing surgery in a Jehovah's Witness patient
  198. Blood Safety/Danger Articles
  199. It is now (2004) clear that there is a risk from the transmission of vCJD via blood
  200. The impact of weekly dosing of epoetin alfa on the haematological parameters and on t
  201. Clinical Pharmacokinetics of Lyophilized Recombinant Human Erythropoietin-[Alpha] Fol
  202. Understanding and managing anemia in critically Ill patients
  203. Erythropoietin Study Defends Use in Cancer Anemia
  204. High Person-to-Person Transmission of Bird Flu Reported
  205. Netherlands Finds Case of Variant Cruetzfeldt-Jakob Disease
  206. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditio
  207. Perioperative blood transfusions and delayed wound healing after hip replacement surg
  208. The Anemia of Primary Autonomic Failure and its Reversal with Recombinant Erythropoie
  209. The role of recombinant human erythropoietin alpha in the treatment of chronic anemia
  210. WBC-containing allogeneic blood transfusion and mortality:
  211. Uses and sources of data on long-term survival after blood transfusion.
  212. Long-term survival after blood transfusion: a population based study in the North UK
  213. Influence of transfusions on perioperative and long-term outcome in patients colorect
  214. Use of erythropoietin for bloodless surgery in a Jehovah's witness infant.
  215. Preoperative recombinant human erythropoietin in anemic surgical patients
  216. Hydroxyurea in thalassemia intermedia-a promising therapy
  217. Blood-Conservation Techniques in Craniofacial Surgery
  218. Intraoperative cell salvage during radical prostatectomy is not associated with great
  219. [Permissive anemia]
  220. Microvascular pressure and functional capillary density in extreme hemodilution with
  221. Anemia impact and management: focus on patient needs and the use of erythropoietic ag
  222. Role of iron in anaemic critically ill patients: it's time to investigate!
  223. Orthopaedic-induced anemia: the fallacy of autologous donation programs.
  224. Influence of body core temperature on blood loss and transfusion requirements during
  225. Use of rituximab to treat refractory Diamond-Blackfan anemia
  226. Evaluation of the Hemobag: a novel ultrafiltration system for circuit salvage.
  227. Preoperative iron supplementation and intraoperative transfusion during colorectal ca
  228. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic dis
  229. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo
  230. Ethics/Legal - Spondyloptotic fracture of the cervical spine in a pregnant, anemic JW
  231. Ethics & Legal - Treatment without consent: a medicolegal precedent
  232. Ethics & Legal The Jehovah's Witness orthopaedic trauma patient: an ethical challenge
  233. Ethics and Legal - In re Estate of Dorone
  234. Ethics and Legal - Davis v. United States
  235. Successful surgical treatment of a ruptured abdominal aortic aneurysm without homolog
  236. Acute isovolaemic haemodilution in two Jehovah's Witnesses presenting for major intra
  237. Treatment of anaemia in the polytrauma Jehovah's Witness
  238. The risk of death for Jehovah's Witnesses after major trauma
  239. Beneficial effect of acute normovolemic hemodilution in cardiovascular surgery
  240. To Do or Not to Do Living Donor Hepatectomy in Jehovah's Witnesses: Single Institutio
  241. Development and validation of a mathematical algorithm for quantifying preoperative b
  242. Blood sparing in craniosynostosis surgery
  243. Acute normovolemic hemodilution: physiology, limitations, and clinical use.
  244. Predictors of transfusion requirements for cardiac surgical procedures at a blood con
  245. Anaesthesia management of major hepatic resections without application of allogeneic
  246. Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic
  247. Acute normovolemic hemodilution
  248. Reading List
  249. Abstract Links/List - Other
  250. Abstract Links/List - Vascular surgery